Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NILOTINIB vs VENETOCLAX: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NILOTINIB vs VENETOCLAX: Safety Overview

Metric NILOTINIB VENETOCLAX
Total FAERS Reports 23,171 53,724
Deaths Reported 4,543 15,763
Death Rate 19.6% 29.3%
Hospitalizations 4,846 20,812
Average Patient Age 56.5 yrs 67.9 yrs
% Female Patients 47.7% 37.6%
FDA Approval Date Dec 15, 2025 Apr 11, 2016
Manufacturer Novadoz Pharmaceuticals LLC AbbVie Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription